| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
HLS Therapeutics Inc (TO: HLS)
HLS Technical Analysis
5
| As on 21st Nov 2024 HLS STOCK Price closed @ 3.31 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.71 & Strong Sell for SHORT-TERM with Stoploss of 5.91 we also expect STOCK to react on Following IMPORTANT LEVELS. |
HLSSTOCK Price
| Open | 3.24 | Change | Price | % |
| High | 3.37 | 1 Day | 0.18 | 5.75 |
| Low | 3.24 | 1 Week | -0.15 | -4.34 |
| Close | 3.31 | 1 Month | -0.46 | -12.20 |
| Volume | 1620 | 1 Year | -1.42 | -30.02 |
| 52 Week High 6.86 | 52 Week Low 3.01 | ||||
TO Canada Most Active Stocks
| YRI | 7.89 | 0.13% |
| ENB | 60.79 | 1.40% |
| CNQ | 48.30 | 2.31% |
| MFC | 45.33 | -1.56% |
| UEX | 0.50 | 16.28% |
| SU | 57.21 | 0.02% |
| CVE | 22.64 | 0.98% |
| SJR-B | 40.48 | 0.02% |
| AC | 23.97 | -2.16% |
| BCE | 37.27 | -1.25% |
TO Canada Top Gainers Stocks
TO Canada Top Losers Stocks
| HLS Daily Charts |
HLS Intraday Charts |
Whats New @ Bazaartrend |
HLS Free Analysis |
|
|
HLS Important Levels Intraday
| RESISTANCE | 3.56 |
| RESISTANCE | 3.48 |
| RESISTANCE | 3.43 |
| RESISTANCE | 3.38 |
| SUPPORT | 3.24 |
| SUPPORT | 3.19 |
| SUPPORT | 3.14 |
| SUPPORT | 3.06 |
HLS Forecast November 2024
| 4th UP Forecast | 8.07 |
| 3rd UP Forecast | 6.54 |
| 2nd UP Forecast | 5.6 |
| 1st UP Forecast | 4.66 |
| 1st DOWN Forecast | 1.96 |
| 2nd DOWN Forecast | 1.02 |
| 3rd DOWN Forecast | 0.08 |
| 4th DOWN Forecast | -1.45 |
HLS Weekly Forecast
| 4th UP Forecast | 5.51 |
| 3rd UP Forecast | 4.80 |
| 2nd UP Forecast | 4.37 |
| 1st UP Forecast | 3.93 |
| 1st DOWN Forecast | 2.69 |
| 2nd DOWN Forecast | 2.25 |
| 3rd DOWN Forecast | 1.82 |
| 4th DOWN Forecast | 1.11 |
HLS Forecast2024
| 4th UP Forecast | 11.25 |
| 3rd UP Forecast | 8.7 |
| 2nd UP Forecast | 7.13 |
| 1st UP Forecast | 5.56 |
| 1st DOWN Forecast | 1.06 |
| 2nd DOWN Forecast | -0.51 |
| 3rd DOWN Forecast | -2.08 |
| 4th DOWN Forecast | -4.63 |
HLS Therapeutics Inc ( TO Canada Symbol : HLS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
HLS Business Profile
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. Its lead product is Clozaril, an atypical antipsychotic used in the treatment of schizophrenia. The company also holds the U.S. marketing rights of Absorica, a commercial stage dermatology product. HLS Therapeutics Inc. has a license agreement with Amarin Corporation plc to register, commercialize, and distribute Vascepa capsules in Canada. The company was founded in 2018 and is headquartered in Toronto, Canada. Address: 10 Carlson Court, Toronto, ON, Canada, M9W 6L2
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service